Indication
Stage IVB Pharyngeal Cancer
1 clinical trial
2 products
2 drugs
Clinical trial
A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other IndicationsStatus: Active (not recruiting), Estimated PCD: 2026-03-31
Drug
AtezolizumabDrug
cetuximabProduct
TemsirolimusProduct
Valproic Acid